|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Operating activities: | ||||
| Net loss | ||||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||
| Allowance for credit losses | ||||
| Reversal of provision for prepayments and other current assets | ||||
| Write-down of inventories | ||||
| Share-based compensation | ||||
| Depreciation and amortization | ||||
| Reduction of carrying amount of right-of-use assets | ||||
| Loss (gain) from equity method investments | ||||
| Gains on sale of an equity security | ||||
| Change in fair value of equity securities | ||||
| Amortization of debt issuance costs | ||||
| Accretion of interest expenses | ||||
| Change in fair value of warrant liabilities | ||||
| Change in fair value of derivative financial assets | ||||
| Change in fair value of derivative financial liabilities | ||||
| Loss/(gain) on disposal of property and equipment, and intangible assets | ||||
| Unrealized exchange losses/(gains) | ||||
| Net unrealized foreign exchange losses/(gains) | ||||
| Impairment of property and equipment and intangible assets | ||||
| Deferred income tax benefit | ||||
| Government grants | ||||
| Noncash interest income | ||||
| Changes in operating assets and liabilities, net of effects of consolidation / deconsolidation of subsidiaries: | ||||
| Accounts receivable | ||||
| Nonrelated Party | ||||
| Related Party | ||||
| Notes receivable | ||||
| Inventories | ||||
| Amounts due from related parties | ||||
| Prepayments and other current assets and other non-current assets | ||||
| Accounts payable | ||||
| Nonrelated Party | ||||
| Related Party | ||||
| Notes payable | ||||
| Contract liabilities | ||||
| Nonrelated Party | ||||
| Related Party | ||||
| Amounts due to related parties | ||||
| Accrued expenses and other current liabilities and income tax payable | ||||
| Operating lease liabilities | ||||
| Provisions | ||||
| Distributions from equity method investees, return on investment | ||||
| Hubei Dongjun Automotive Electronics Technology Co., Ltd. | ||||
| Total distributions from equity method investees, return on investment | ||||
| Net cash used in operating activities | ||||
| Investing activities: | ||||
| Cash paid for acquisition of short-term investments | ||||
| Proceeds from redemption of short-term investments | ||||
| Loans and advances to related parties | ||||
| Cash collection of loans to related parties and advances to related parties | ||||
| Cash paid for acquisition of equity method investments | ||||
| Proceeds from sale of HaleyTek AB | ||||
| Proceeds from sale of equity method investments | ||||
| Payments for acquisition, net of cash acquired | ||||
| Hubei Dongjun Automotive Electronics Technology Co., Ltd. | ||||
| Suzhou Photon-Matrix | ||||
| Cash disposed on deconsolidation of Suzhou Photon-Matrix | ||||
| Hubei Dongjun Automotive Electronics Technology Co., Ltd. | ||||
| Suzhou Photon-Matrix | ||||
| Cash received on deconsolidation of Hubei Dongjun | ||||
| Financial support to an equity method investee | ||||
| Cash received from partial sale of equity interest in SiEngine | ||||
| Receivables from partial sale of equity interest in SiEngine | ||||
| Receivables from shares issued upon exercise of options | ||||
| Transfer of notes receivable as part of consideration to purchase intangible assets | ||||
| Re-designation of ordinary shares to Series A Preferred Shares (Note 18) | ||||
| Shares issued | ||||
| Non-cash assets distributed to shareholders of the company in the Restructuring (Note 1(c)) | ||||
| Payable for issuance cost of convertible notes payable | ||||
| Amounts due from a related party for sale of Zenseact | ||||
| Issuance of ordinary shares in exchange for an equity security | ||||
| Payables for costs of the Merger | ||||
| Conversion of Convertible Redeemable Preferred Shares to ordinary shares (Note 1(b) and Note 19) | ||||
| Conversion of convertible notes payable to Class A Ordinary Shares | ||||
| Issuance of ordinary shares through conversion of convertible notes | ||||
| Waiver of loan receivables from a related party under common control | ||||
| Debt assignment and offset with related parties | ||||
| Proceeds from sale of Zenseact | ||||
| Payments for available-for-sale debt investments | ||||
| Payments for equity securities | ||||
| Purchase of property and equipment, and intangible assets | ||||
| Proceeds from disposal of property and equipment, and intangible assets | ||||
| Distributions from equity method investees in excess of cumulative earnings | ||||
| Net cash (used in) provided by investing activities | ||||
| Financing activities: | ||||
| Repayment of refundable deposits in connection with the issuance of Series A Convertible Redeemable Preferred Shares | ||||
| Cash contributed by redeemable noncontrolling shareholders | ||||
| Cash contributed by non-redeemable non-controlling shareholders | ||||
| Proceeds from short-term borrowings | ||||
| Repayment of short-term borrowings | ||||
| Proceeds from long-term borrowings | ||||
| Borrowings from related parties | ||||
| Repayments of borrowings from related parties | ||||
| Repayment of long-term debt | ||||
| Acquisition of an entity under common control | ||||
| Cash payment not soon after purchase of intangible assets | ||||
| Cash disposed in restructuring | ||||
| Cash proceeds from COVA | ||||
| Cash proceeds from Geely strategic investment | ||||
| Cash paid to acquire noncontrolling interests | ||||
| Cash payment not soon after a business acquisition of Hubei Dongjun | ||||
| Proceeds from employee stock option exercises | ||||
| Proceeds from issuance of ordinary shares | ||||
| Cash paid for follow-on public offering cost | ||||
| Series A+ Redeemable Convertible Preferred Shares | ||||
| Total cash paid for follow-on public offering cost | ||||
| Refundable deposits in connection with the issuance of Convertible Redeemable Preferred Shares | ||||
| Cash paid for repurchase of ordinary shares | ||||
| Proceeds from issuance of convertible notes | ||||
| Payment for issuance costs of convertible notes | ||||
| Repayments of convertible notes | ||||
| Cash paid for costs of the Merger | ||||
| Proceeds from conditional government grants | ||||
| Net cash provided by financing activities | ||||
| Effect of foreign currency exchange rate changes on cash and restricted cash | ||||
| Net decrease in cash and restricted cash | ||||
| Cash and restricted cash at the beginning of the year | ||||
| Cash and restricted cash at the end of the year | ||||
| Supplemental information: | ||||
| Income tax paid | ||||
| Interest paid | ||||
| Non-cash investing and financing activities: | ||||
| Payable for purchase of property and equipment, and intangible assets | ||||
| Reconciliation of cash and restricted cash: | ||||
| Cash | ||||
| Restricted cash | ||||
Loading...